TransMedics (TMDX) Operating Leases (2021 - 2026)

TransMedics' Operating Leases history runs 6 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Operating Leases fell 47.78% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (down 47.78% YoY), while the FY2025 annual figure was $3.6 million, down 42.76% from the prior year.
• Operating Leases was $2.9 million for Q1 2026 at TransMedics, down from $3.6 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $8.5 million in Q1 2022 to a low of $2.9 million in Q1 2026.
• Historically, Operating Leases has averaged $6.6 million across 5 years, with a median of $7.1 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Operating Leases climbed 5.71% in 2023, then tumbled 47.78% in 2026.
• A 5-year view of Operating Leases shows it stood at $7.4 million in 2022, then rose by 3.94% to $7.7 million in 2023, then declined by 18.92% to $6.2 million in 2024, then plunged by 42.76% to $3.6 million in 2025, then decreased by 19.4% to $2.9 million in 2026.
• The last three Operating Leases figures came in at $2.9 million (Q1 2026), $3.6 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.